Outcomes of Patients Who Develop Bacteremia in the First 100 Days after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis | Researchclopedia
Outcomes of Patients Who Develop Bacteremia in the First 100 Days after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis